임신 중 minoxidil succinoyl oligopeptide-143을 피해야 할까요? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

Pregnancy-safe products to use instead

Products built around the safer ingredients above, scored "no known risks" or "low risk".

Unknown

100

schmidts here now

L'Occitane

100

L´Occitane Powder To-mousse Facial Exfoliator

Sustain Yourself

100

Sustain Yourself Natural Deodorant

Bitamin

100

Bitamin Natural Deodorant N'orange

Mew mew tweet

100

Mew mew tweet Cedar Spruce Baking Soda Free

Avero

100

Avero Solid Deodorant

Avril

99

Déodorant baume

HappySoaps

99

Happysoaps Neutraal

Laura Mercier

99

Laura Mercier Tinted Moisturizer Broad Spectrum Spf 20 - Oil Free

Woohoo

99

Woohoo Deodorant & Anti-Chafe Stick

임신 중 minoxidil succinoyl oligopeptide-143 대체 안전 성분 | VeriMom

성분 — 성분

더 보기

• minoxidil succinoyl oligopeptide-143은(는) 임신 중 안전한가요?
• minoxidil succinoyl oligopeptide-143은(는) 아기에게 안전한가요?
• minoxidil succinoyl oligopeptide-143의 임신 중 안전한 대안은 무엇인가요?

FAQ

minoxidil succinoyl oligopeptide-143은 임신 중 안전한가요?

Minoxidil (6-(piperidinyl)-2,4-pyrimidinediamine-3-oxide) is listed as a substance that must not form part of the composition of cosmetics in EU Annexes (minoxidil and its salts appear in the prohibited list), which by your rules requires h≥2. Topical minoxidil is systemically absorbed in measurable amounts and there are case reports of effects in infants after dermal exposure; therefore a mechanism of systemic exposure is plausible. No SCCS/CIR opinion or harmonised H360/H361 specific to the peptide was found; evidence is via minoxidil data and regulatory prohibition. Sources: EU Annex listing, PubChem/minoxidil, EMA safety note on infant hypertrichosis.

minoxidil succinoyl oligopeptide-143은 모유 수유 중 안전한가요?

Minoxidil is a pharmacologically active systemic agent with reports of infant effects after maternal topical use and some evidence of transmission/infant exposure; regulatory guidance warns about infant hypertrichosis following skin contact. Thus breastfeeding safety is a concern (h=2). Mechanistic concern is demonstrated systemic exposure; measured transfer into milk is not well-quantified in public cosmetic dossiers, so exposure is graded as low but measurable for breastfeeding (e=1).

minoxidil succinoyl oligopeptide-143은 아기 피부에 안전한가요?

For dermal contact with infants (0–3 yr) there are case reports of excessive hair growth in infants after parental topical minoxidil use/contact, and infants have higher dermal uptake (immature barrier and higher surface-area-to-weight). Therefore hazard and mechanism scores follow minoxidil (h=2, m=2) and exposure is increased (adult e=2 → infant e=3 per your rules). No infant-specific toxicology studies for the peptide were found; the concern is driven by the minoxidil parent compound and case reports.

VeriMom은 minoxidil succinoyl oligopeptide-143을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 minoxidil succinoyl oligopeptide-143을 33/100 (높은 위험)로 평가합니다.

임신 중 minoxidil succinoyl oligopeptide-143 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.